University of Toronto
VC Fund
Toronto, Canada
University of Toronto is a VC fund in Toronto focused on Health Care and Biotechnology. Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. The University of Toronto is committed to being an internationally significant researchuniversity, with undergraduate, graduate and professional programs of excellent quality.The University of Toronto is dedicated to fostering an academic community in which the learning and scholarship of every member may flourish, with vigilant protection for individual human rights, and a resolute commitment to the principles of equal opportunity, equity and justice.Within the unique university context, the most crucial of all human rights are the rights of freedom of speech, academic freedom, and freedom of research. And we affirm that these rights are meaningless unless they entail the right to raise deeply disturbing questions and provocative challenges to the cherished beliefs of society at large and of the university itself.It is this human right to radical, critical teaching and research with which the University has a duty above all to be concerned; for there is no one else, no other institution and no other office, in our modern liberal democracy, which is the custodian of this most precious and vulnerable right of the liberated human spirit.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries University of Toronto invests in
Stages University of Toronto invests in
Countries University of Toronto invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jon French
|
|||
Molly S. Shoichet
|
|||
Stewart Aitchison
|
|||
Theodore J. Witek, Jr
|
|||
| See all 25 contacts → | |||
Investment Focus
Industry
- Health Care 3 (19%)
- Biotechnology 3 (19%)
- Medical 2 (13%)
- Software 2 (13%)
- Education 2 (13%)
Stage
- Grant 6 (38%)
- Seed 5 (31%)
- Pre-Seed 5 (31%)
Country
- Canada 14 (88%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Geoffrey Hinton
Professor
|
Professor | Total investments: 6 | Find email | |
|
Jon French
Director
|
Director | Total investments: 0 | Find email | |
|
Molly S. Shoichet
Professor, Chemical Engineering & Applied Chemistry
|
Professor, Chemical Engineering & Applied Chemistry | Total investments: 0 | Find email | |
|
Stewart Aitchison
Professor in Electrical and Computer Eng.
|
Professor in Electrical and Computer Eng. | Total investments: 0 | Find email | |
|
Theodore J. Witek, Jr
Professor
|
Professor | Total investments: 0 | Find email | |
| See all 25 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
aiphrodite.ai
|
aiphrodite.ai is an AdTech SaaS platform that predicts visual and textual ad performance across all mediums through artificial intelligence personas (AI Personas) that replicate your customers. | $4.7K / Grant / Jan 29, 2022 | |
TransCrypts
|
TransCrypts is a tool for Human Resource Departments to automate the issuance of employment and income verification documents using the blockchain. Our proprietary process not only saves HRs time, money, and headache in dealing with compliance but also gives employees total control over how their work information is being shared. | Grant / May 30, 2021 | |
Dalriada Therapeutics
|
Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY model, where R&D is perfectly aligned with business and IP. | $25K / Grant / Nov 13, 2020 | |
Inteligex
|
Inteligex is developing proprietary stem cell-based therapeutics to restore function in patients with spinal cord injury— a devastating condition for which there is no effective therapy — and for other diseases of the Central Nervous System. Successful outcomes from the development program would position Inteligex as the first in the world with atreatment affecting hundreds of thousand patients worldwide. | Grant / Sep 01, 2020 | |
African Impact Initiative
|
The African Impact Initiative is dedicated to creating a platform for impacting the African community through its youth. It enables this through initiatives centered around community impact, professional development, and impact entrepreneurship. | $73K / Pre-Seed / Mar 22, 2020 | |
|
African Impact Initiative
|
The African Impact Initiative is dedicated to creating a platform for impacting the African community through its youth. It enables this through initiatives centered around community impact, professional development, and impact entrepreneurship. | $69.1K / Grant / Mar 22, 2020 | |
Cohesys
|
Cohesys uses inspiration from nature to create the next generation of surgical adhesives that are strong enough to replace titanium screws in craniomaxillofacial (CMF) fracture fixation. Its technology employs a resorbable, flexible polymer tape and bio-inspired adhesive system, resulting in safer and faster CMF fracture fixation procedures. | $30K / Grant / May 16, 2019 | |
TissueX Technologies
|
TissueX Technologies is a Toronto-based biotechnology company focused on improving the efficiency of drug discovery by increasing the predictability and quantification power of cell-based assays used in preclinical drug development. | Seed / Mar 21, 2019 | |
Ardra Bio
|
Ardra is a startup based on technology developed at the University of Toronto. Their technology uses model-guided metabolic engineering and synthetic biology to develop biocatalysts for the production of specialty chemicals from renewable resources. Their current target is the cosmetics industry, which uses $2.6 billion worth of petroleum chemicalsin a variety of products. | Pre-Seed / Nov 20, 2015 | |
Onyx Motion
|
Onyx Motion is a developer of sports coaching applications for apple and android smartwatches. | Seed / Jul 08, 2015 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does University of Toronto invest in?
University of Toronto invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Seed stage. Most of the 16 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact University of Toronto?
Public channels for University of Toronto include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at University of Toronto?
The team at University of Toronto includes Geoffrey Hinton (Professor), Jon French (Director) and Molly S. Shoichet (Professor, Chemical Engineering & Applied Chemistry), among 25 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
